NCT03999853View on ClinicalTrials.gov

Butyrate Adjuvant Therapy for Type 1 Diabetes

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 28, 2022

Primary Completion Date

April 1, 2025

Study Completion Date

December 31, 2025

Conditions
Type1diabetes
Interventions
DRUG

BKR-017

BKR-017

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

BioKier Inc.

INDUSTRY

collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

Mayo Clinic

OTHER